A phase 1B, open-label, dose-escalation study of bortezomib in combination with gemcitabine (Gem) and cisplatin (Cis) in the first-line treatment of patients with advanced solid tumors: Preliminary ...
Adjuvant chemotherapy prolongs disease-free survival (DFS) and overall survival (OS) following surgery in patients with colorectal cancer. Although it is known that biomodulation of 5-fluorouracil ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results